Safe weed killers are important in any garden space, but they are even more important in a vegetable garden with crops that ...

Oct. 2, 2024 — Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in ... Cannabinoid CBG Reduces ...

Election Day is Tuesday and in four states, voters will have the opportunity to cast their thoughts on the future of marijuana legislation. Here's what to know about marijuana legislation and what ...

Legalizing marijuana at the national level is generally popular with Americans — 57% of people say marijuana should be legal for both medical and recreational purposes, while 32% say it should ...

If enough voters go for it in November, recreational marijuana for adult use will become legal in Florida. Critics and politicians — led by Florida Governor Ron DeSantis — have argued about ...

Marijuana stocks have given cannabis investors nothing but false starts over the past few years. The industry has struggled with a plethora of issues, including inflation, overproduction, lack of ...

If you're an investor in the legal marijuana industry, or are thinking about becoming one, there's a key attribute you'll need: patience. It was about a decade ago that the cannabis bubble was in ...

Florida voters heading to the polls on Election Day have the chance to say "yes" or "no" to Amendment 3, which seeks to legalize marijuana for recreational use and change the state's constitution.

Marijuana’s humid growing conditions are a paradise for dangerous mold. States where marijuana is legal make growers hire laboratories to check for concentrations of mold and other contaminants ...

Opinions expressed by Forbes Contributors are their own. A.J. Herrington is freelance writer covering weed news and culture. Former president and Republican presidential nominee Donald Trump on ...

Readers respond to a front-page article about the growing use of marijuana after legalization. To the Editor: Re “Unexpected Problem in the Rise of Marijuana” (front page, Oct. 5): As we ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. Vice President ...